A novel diagnostic model for insulinoma
-
Published:2022-08-02
Issue:1
Volume:13
Page:
-
ISSN:2730-6011
-
Container-title:Discover Oncology
-
language:en
-
Short-container-title:Discov Onc
Author:
Wang Feng,Yang Zhe,Chen XiuBing,Peng Yiling,Jiang HaiXing,Qin ShanYu
Abstract
AbstractThe aim is to describe a simple and feasible model for the diagnosis of insulinoma. This retrospective study enrolled 37 patients with insulinoma and 44 patients with hypoglycemia not due to insulinoma at the First Affiliated Hospital of Guangxi Medical University. General demographic and clinical characteristics; hemoglobin A1c (HbA1c), insulin and C-peptide concentrations; and the results of 2-h oral glucose tolerance tests (OGTT) were recorded, and a logistic regression model predictive of insulinoma was determined. Body mass index (BMI), HbA1c concentration, 0-h C-peptide concentration, and 0-h and 1-h plasma glucose concentrations (P < 0.05 each) were independently associated with insulinoma. A regression prediction model was established through multivariate logistics regression analysis: Logit p = 7.399+(0.310 × BMI) − (1.851 × HbA1c) − (1.467 × 0-h plasma glucose) + (1.963 × 0-h C-peptide) − (0.612 × 1-h plasma glucose). Using this index to draw a receiver operating characteristic (ROC) curve, the area under the curve (AUC) was found to be 0.957. The optimal cut-off value was − 0.17, which had a sensitivity of 89.2% and a specificity of 86.4%. Logit P ≥ − 0.17 can be used as a diagnostic marker for predicting insulinoma in patients with hypoglycemia.
Funder
Guangxi Medical High-level Key Talents “139” Training Program
National Natural Science Foundation of China
Special Fund for Characteristic Innovation Team of Guangxi Natural Science Foundation
Technology development and promotion
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Endocrine and Autonomic Systems,Endocrinology,Oncology,Endocrinology, Diabetes and Metabolism
Reference34 articles.
1. Morera J, Reznik Y. Insulinoma. Rev Prat. 2019;69:e250-0.
2. Tuzcu SA, Pekkolay Z, Kilinc F, Tuzcu AK. 68Ga-DOTATATE PET/CT can be an alternative imaging method in insulinoma patients. J Nucl Med Technol. 2017;45:198–200.
3. Vaidakis D, Karoubalis J, Pappa T, Piaditis G, Zografos GN. Pancreatic insulinoma: current issues and trends. Hepatobiliary Pancreat Dis Int. 2010;9:234–41.
4. Larijani B, Aghakhani S, Lor SSM, Zahedi F, Pajouhi M, et al. Insulinoma in Iran: a 20-year review. Ann Saudi Med. 2005;25:477–80.
5. Ma H, Zhang XP, Zhang Y, Lu HD, Wang JT, et al. Pancreatic Insulinoma misdiagnosed as epilepsy for eight years: a case report and literature review. Intern Med. 2015;54:1519–22.